Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia

Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia

Show other versions (2)

The results from the need to develop methodologies for performing cost analysis in developing countries, principally in the region of Latin America, were studied. It, furthermore, serves to generate knowledge from an economic evaluation in order to support decision-making related to the organization...

Full description

Bibliographic Details
Main Authors: Armando Arredondo, Lejeune Y. Lockett, Esteban de Icaza
Format: Article
Language:English
Published: Universidade de São Paulo
Series:Revista de Saúde Pública
Subjects:
health care costs
cost control
health economics
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89101995000500003&lng=en&tlng=en
id doaj-6ed9f575817c4c6abc973f1127e6dffb
record_format Article
spelling doaj-6ed9f575817c4c6abc973f1127e6dffb2020-11-25T03:12:07ZengUniversidade de São PauloRevista de Saúde Pública0034-89101518-8787295349354S0034-89101995000500003Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumoniaArmando Arredondo0Lejeune Y. Lockett1Esteban de Icaza2Instituto Nacional de Salud Pública de MéxicoInstituto Nacional de Salud Pública de MéxicoInstituto Nacional de Salud Pública de MéxicoThe results from the need to develop methodologies for performing cost analysis in developing countries, principally in the region of Latin America, were studied. It, furthermore, serves to generate knowledge from an economic evaluation in order to support decision-making related to the organization of health systems, particularly in the efficient use of resources which are allocated for the provision of medical services. Two chronic diseases (breast cancer and cardiac valve disease) and two infections (enteritis and bronchopneumonia) were selected for the study. The results recommend the use of a valid methodology for economic cost analysis of any disease to be studied and the use of this information in the decision-making process.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89101995000500003&lng=en&tlng=enhealth care costscost controlhealth economics
collection DOAJ
language English
format Article
sources DOAJ
author Armando Arredondo
Lejeune Y. Lockett
Esteban de Icaza
spellingShingle Armando Arredondo
Lejeune Y. Lockett
Esteban de Icaza
Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
Revista de Saúde Pública
health care costs
cost control
health economics
author_facet Armando Arredondo
Lejeune Y. Lockett
Esteban de Icaza
author_sort Armando Arredondo
title Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
title_short Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
title_full Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
title_fullStr Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
title_full_unstemmed Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
title_sort cost of diseases in brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia
publisher Universidade de São Paulo
series Revista de Saúde Pública
issn 0034-8910
1518-8787
description The results from the need to develop methodologies for performing cost analysis in developing countries, principally in the region of Latin America, were studied. It, furthermore, serves to generate knowledge from an economic evaluation in order to support decision-making related to the organization of health systems, particularly in the efficient use of resources which are allocated for the provision of medical services. Two chronic diseases (breast cancer and cardiac valve disease) and two infections (enteritis and bronchopneumonia) were selected for the study. The results recommend the use of a valid methodology for economic cost analysis of any disease to be studied and the use of this information in the decision-making process.
topic health care costs
cost control
health economics
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89101995000500003&lng=en&tlng=en
work_keys_str_mv AT armandoarredondo costofdiseasesinbrazilbreastcancerenteritiscardiacvalvediseaseandbronchopneumonia
AT lejeuneylockett costofdiseasesinbrazilbreastcancerenteritiscardiacvalvediseaseandbronchopneumonia
AT estebandeicaza costofdiseasesinbrazilbreastcancerenteritiscardiacvalvediseaseandbronchopneumonia
_version_ 1724651452158181376

Similar Items